Philippe Saiag
Boulogne-billancourt, 92100, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 163 publications
The Role of General Practitioners in Actinic Keratosis Management in Europe: A Dermato-Oncologists Initiative.
Journal: Journal of clinical medicine
Published: June 30, 2026
Real-World Use of Adjuvant Nivolumab for Resected Stage III-IV Melanoma: 2-Year Analysis of AdjuMel.
Real-World Use of Adjuvant Nivolumab for Resected Stage III-IV Melanoma: 2-Year Analysis of AdjuMel.
Journal: Dermatology and therapy
Published: March 20, 2026
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention - Update 2026.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 19, 2026
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment - update 2026.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 19, 2026
Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study.
Journal: Journal for immunotherapy of cancer
Published: February 23, 2026
Prognostic classification of skin adnexal carcinomas: Results from a prospective study of 980 patients in the French CARADERM network.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 22, 2026
International Dermoscopy Society consensus recommendations for the management of lentigo maligna.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: October 11, 2025
Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCA.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 22, 2025
Erratum: BO-112 Plus Pembrolizumab for Patients With Anti-PD-1-Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 24, 2025
BO-112 Plus Pembrolizumab for Patients With Anti-PD-1-Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 27, 2025
Messages for ultraviolet-radiation protection to fair-skinned populations.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: May 28, 2025
Management of Local Skin Reactions Caused by 5-FU 4% Cream for the Treatment of Actinic Keratosis: A Delphi Consensus.
Journal: Dermatology practical & conceptual
Published: March 18, 2025
Last Updated: 09/26/2026